Fig. 5From: RB1 and TP53 co-mutations correlate strongly with genomic biomarkers of response to immunity checkpoint inhibitors in urothelial bladder cancerKaplan Meier curves using the TMM as a continuous variable split by A) the median B) the first quartile in the urothelial bladder cancer TCGA datasetBack to article page